Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia-Reference-Cited by-同舟云学术

Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia

Published:2016-08-22 Issue:38 Volume:7 Page:62377-62385
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Boyer Thomas¹²,Guihard Soizic²,Roumier Christophe¹,Peyrouze Pauline²,Gonzales Fanny²,Berthon Céline²³,Quesnel Bruno²³,Preudhomme Claude¹²,Behal Hélène⁴,Duhamel Alain⁴,Roche-Lestienne Catherine²⁵,Cheok Meyling²

Affiliation:

1. Hematology Laboratory, Biology and Pathology Center, CHRU Lille, France

2. Jean-Pierre AUBERT Research Center, UMR-S1172, Lille, France

3. Department of Hematology, Claude Huriez Hospital, CHRU Lille, France

4. Department of Biostatistics, Univ. Lille, CHU Lille, EA 2694 - Santé Publique: Épidémiologie et Qualité des Soins, F-59000 Lille, France

5. Institute of Medical Genetics, Jeanne de Flandre Hospital, CHRU Lille, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia;Genome Medicine;2023-10-16

2. Tetraspanin CD81 promotes leukemia stem cell function and represents a new therapeutic vulnerability in acute myeloid leukemia;2023-09-26

3. Tetraspanin CD81 is expressed in human parotid cancer tissue and mediates cell proliferation;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2023-08

4. CD81 and Its Relationship to Treatment Response in Patients With Acute Myeloid Leukemia at a Hospital in Hanoi, Vietnam;Cureus;2023-06-11

5. Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases;Cancers;2023-04-06